Skip to main content
. Author manuscript; available in PMC: 2014 Aug 19.
Published in final edited form as: Mol Imaging Biol. 2011 Feb;13(1):94–103. doi: 10.1007/s11307-010-0320-2

Fig. 3.

Fig. 3

Representative ve maps of groups 1–4 before dosing (day 0) or 3 days posttherapy (day 3) in a a whole tumor region or b peripheral tumor region with a constant scale (from 0 to 0.7). c, d ve changes of the four groups during 3 days posttherapy in c whole tumor region or d peripheral tumor region. Different Greek letters present statistical differences among groups during 3 days.